112 related articles for article (PubMed ID: 1149027)
1. Characterization of a chimpanzee anti-human melanoma antiserum.
Stuhlmiller GM; Seigler HF
Cancer Res; 1975 Aug; 35(8):2132-7. PubMed ID: 1149027
[TBL] [Abstract][Full Text] [Related]
2. [Basis for a specific-active immunotherapy in malignant melanoma].
Mutzner PA; Stuhlmiller GM; Seigler HF; Stumpf WE; Sar M
Schweiz Med Wochenschr; 1981 Sep; 111(36):1322-5. PubMed ID: 7302537
[TBL] [Abstract][Full Text] [Related]
3. Cell-mediate cytotoxicity in vitro of human lymphocytes against a tissue culture melanoma cell line (igr3).
Peter HH; Pavie-Fischer J; Fridman WH; Aubert C; Cesarini JP; Roubin R; Kourilsky FM
J Immunol; 1975 Aug; 115(2):539-48. PubMed ID: 1171141
[TBL] [Abstract][Full Text] [Related]
4. Cloned human cytotoxic T lymphocyte (CTL) lines reactive with autologous melanoma cells. I. In vitro generation, isolation, and analysis to phenotype and specificity.
de Vries JE; Spits H
J Immunol; 1984 Jan; 132(1):510-9. PubMed ID: 6197458
[TBL] [Abstract][Full Text] [Related]
5. Human melanoma and leukemia associated antigens difined by nonhuman primate antisera.
Seigler HF; Metzgar RS; Mohanakumar T; Stuhlmiller GM
Fed Proc; 1975 Jul; 34(8):1642-6. PubMed ID: 805717
[TBL] [Abstract][Full Text] [Related]
6. Production of antisera with specificity for malignant melanoma and human fetal skin.
Fritze D; Kern DH; Drogemuller CR; Pilch YH
Cancer Res; 1976 Feb; 36(2 Pt 1):458-66. PubMed ID: 56991
[TBL] [Abstract][Full Text] [Related]
7. Detection of naturally processed and HLA-A1-presented melanoma T-cell epitopes defined by CD8(+) T-cells' release of granulocyte-macrophage colony-stimulating factor but not by cytolysis.
Maeurer MJ; Martin D; Elder E; Storkus WJ; Lotze MT
Clin Cancer Res; 1996 Jan; 2(1):87-95. PubMed ID: 9816095
[TBL] [Abstract][Full Text] [Related]
8. Spontaneous cytotoxicity (SCMC) of normal human lymphocytes against a human melanoma cell line: a phenomenon due to a lymphotoxin-like mediator.
Peter HH; Eife RF; Kalden JR
J Immunol; 1976 Feb; 116(2):342-8. PubMed ID: 1082453
[TBL] [Abstract][Full Text] [Related]
9. "Hidden" cytotoxic antibodies that react with allogeneic cultured fetal and tumor cells contained in soluble immune complexes from normal human sera.
Morgan AC; Rossen RD; McCormick KJ; Stehlin JS; Giovanella BC
Cancer Res; 1982 Mar; 42(3):881-7. PubMed ID: 7059986
[TBL] [Abstract][Full Text] [Related]
10. Human malignant melanoma cells: morphological and immunological variations.
Hakim AA
Neoplasma; 1977; 24(1):81-99. PubMed ID: 840339
[TBL] [Abstract][Full Text] [Related]
11. Expression of HLA-A2 antigen in human melanoma cell lines and its role in T-cell recognition.
Pandolfi F; Boyle LA; Trentin L; Kurnick JT; Isselbacher KJ; Gattoni-Celli S
Cancer Res; 1991 Jun; 51(12):3164-70. PubMed ID: 1904004
[TBL] [Abstract][Full Text] [Related]
12. Common expression of melanoma tumor-associated antigens recognized by human tumor infiltrating lymphocytes: analysis by human lymphocyte antigen restriction.
Hom SS; Topalian SL; Simonis T; Mancini M; Rosenberg SA
J Immunother (1991); 1991 Jun; 10(3):153-64. PubMed ID: 1868040
[TBL] [Abstract][Full Text] [Related]
13. Generation of tumor-specific CTLs from melanoma patients by using peripheral blood stimulated with allogeneic melanoma tumor cell lines. Fine specificity and MART-1 melanoma antigen recognition.
Stevens EJ; Jacknin L; Robbins PF; Kawakami Y; el Gamil M; Rosenberg SA; Yannelli JR
J Immunol; 1995 Jan; 154(2):762-71. PubMed ID: 7814882
[TBL] [Abstract][Full Text] [Related]
14. The role of HLA class I antigens in recognition of melanoma cells by tumor-specific cytotoxic T lymphocytes. Evidence for shared tumor antigens.
Darrow TL; Slingluff CL; Seigler HF
J Immunol; 1989 May; 142(9):3329-35. PubMed ID: 2785141
[TBL] [Abstract][Full Text] [Related]
15. Induction of cytotoxic T lymphocytes from the peripheral blood of a hepatocellular carcinoma patient using melanoma antigen-1 (MAGE-1) peptide.
Lu J; Leng X; Peng J; Mou D; Pang X; Shang X; Chen W
Chin Med J (Engl); 2002 Jul; 115(7):1002-5. PubMed ID: 12150730
[TBL] [Abstract][Full Text] [Related]
16. Reactivity of autologous CD4+ T lymphocytes against human melanoma. Evidence for a shared melanoma antigen presented by HLA-DR15.
Takahashi T; Chapman PB; Yang SY; Hara I; Vijayasaradhi S; Houghton AN
J Immunol; 1995 Jan; 154(2):772-9. PubMed ID: 7814883
[TBL] [Abstract][Full Text] [Related]
17. Expression of fetal antigens by normal human skin cells grown in tissue culture.
Thorpe WP; Parker GA; Rosenberg SA
J Immunol; 1977 Sep; 119(3):818-23. PubMed ID: 330754
[TBL] [Abstract][Full Text] [Related]
18. Simplification of B-cell antisera of the Merrit system with platelets and lymphoblastoid cell lines.
Naeim F; Gregg B; Gatti RA; Leibold W; Walford RL
Transplant Proc; 1977 Mar; 9(1):439-44. PubMed ID: 68582
[TBL] [Abstract][Full Text] [Related]
19. Generation of melanoma-specific, cytotoxic CD4(+) T helper 2 cells: requirement of both HLA-DR15 and Fas antigens on melanomas for their lysis by Th2 cells.
Zennadi R; Abdel-Wahab Z; Seigler HF; Darrow TL
Cell Immunol; 2001 Jun; 210(2):96-105. PubMed ID: 11520076
[TBL] [Abstract][Full Text] [Related]
20. Shared human melanoma antigens. Recognition by tumor-infiltrating lymphocytes in HLA-A2.1-transfected melanomas.
Kawakami Y; Zakut R; Topalian SL; Stötter H; Rosenberg SA
J Immunol; 1992 Jan; 148(2):638-43. PubMed ID: 1729379
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]